Altimmune To Announce Year End 2020 Financial Results on February 25, 2021

Nachrichtenquelle: globenewswire
22.02.2021, 22:30  |  46   |   |   

GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its full year 2020 financial results on Thursday, February 25th, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am ET on Thursday, February 25th, 2021 to discuss financial results and provide a business update.

Conference Call Information:

Date:    Thursday, February 25, 2021
Time:   8:30 am Eastern Time
Domestic Dial-in:     877-423-9813
International Dial-in:       201-689-8573
Conference ID:   13716171
Webcast:       http://public.viavid.com/index.php?id=143423

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). For more information on Altimmune, please visit www.altimmune.com.

Investor & Media Contacts:

Will Brown Stacey Jurchison
Chief Financial Officer                                    Sr. Dir, Investor Relations
Phone: 240-654-1450      Phone : 410-474-8200  
wbrown@altimmune.com      sjurchison@altimmune.com 



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Altimmune To Announce Year End 2020 Financial Results on February 25, 2021 GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) - Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its full year 2020 financial results on Thursday, February 25th, 2021. Altimmune …

Nachrichten des Autors

Titel
Titel
Titel
Titel